Penile Squamous Cell Carcinoma

• CLINICAL_TRIALS research · 2026-04-16
  Clinical Trial Update: DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma [Phase 2]

  This Phase II trial investigates first-line therapy with enfortumab vedotin plus avelumab for advanced penile squamous cell carcinoma; the s…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas [Phase 1]

  Phase 1 study evaluating safety, efficacy, and pharmacokinetics of EVOLVE104 in patients with advanced urothelial cancer and squamous cell c…

• CLINICAL_TRIALS research · 2026-04-13
  Clinical Trial Update: Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors [Phase 1]

  Phase 1 trial evaluating cabozantinib S-malate with nivolumab, with or without ipilimumab, in patients with metastatic genitourinary tumors;…

• CLINICAL_TRIALS research · 2026-04-07
  Clinical Trial Update: MRG003 Plus HX008 as First-Line Treatment for EGFR-Positive Locally Advanced or Metastatic Penile Squamous Cell Carcinoma [Phase 1]

  Phase 1 trial evaluating MRG003 plus HX008 as first-line therapy for EGFR-positive locally advanced or metastatic penile cancer. The study i…

• CLINICAL_TRIALS research · 2026-03-11
  Clinical Trial Update: Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors [Phase 2]

  A Phase 2 trial investigates the combination of atezolizumab and bevacizumab in several rare solid tumors, with the study currently not recr…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2025-12-11
  Clinical Trial Update: Enfortumab Vedotin for the Treatment of Patients With Metastatic or Unresectable Squamous Cell Carcinoma of the Penis [Phase 2]

  A Phase 2 clinical trial update for enfortumab vedotin in patients with metastatic or unresectable penile squamous cell carcinoma, with recr…

• CLINICAL_TRIALS research · 2025-12-08
  Clinical Trial Update: Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer [Phase 2]

  Phase 2 clinical trial evaluating carboplatin/paclitaxel in combination with pembrolizumab for locoregionally advanced penile cancer; curren…

• CLINICAL_TRIALS research · 2025-06-26
  Clinical Trial Update: Evaluation of Lymphadenectomy and Chemotherapy TIP on Inguinal Lymph Nodes in Squamous Cell Carcinoma of the Penis [Phase 2]

  A Phase 2 trial evaluating lymphadenectomy plus TIP chemotherapy for penile cancer with inguinal lymph node involvement; the study is curren…

• CLINICAL_TRIALS research · 2025-04-02
  Clinical Trial Update: International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) [Phase 3]

  This is a Phase 3 international trial for penile squamous cell carcinoma that is currently recruiting under the International Rare Cancers I…

• CLINICAL_TRIALS research · 2024-08-23
  Clinical Trial Update: Prediction of Local Recurrence and Its Impact on Long-term Outcomes After Low-risk Glans-sparing Surgery for Penile Squamous Cell Carcinoma

  This clinical trial update outlines a study aiming to predict local recurrence after low-risk glans-sparing surgery for penile squamous cell…

• CLINICAL_TRIALS research · 2024-07-17
  Clinical Trial Update: Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma [Phase 1, Phase 2]

  Phase 1/2 trial evaluating autologous SCG142 TCR T cells for HPV16/52-positive squamous cell carcinomas across multiple HPV-related sites; c…